Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 12 12 2023
accepted: 19 04 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

In this study, new series of N'-(2-(substitutedphenoxy)acetyl)-4-(1H-pyrrol-1-yl)benzohydrazides (3a-j) 4-(2,5-dimethyl-1H-pyrrol-1-yl)-N'-(2-(substitutedphenoxy)acetyl)benzohydrazides (5a-j) were synthesized, characterized and assessed as inhibitors of enoyl ACP reductase and DHFR. Most of the compounds exhibited dual inhibition against the enzymes enoyl ACP reductase and DHFR. Several synthesized substances also demonstrated significant antibacterial and antitubercular properties. A molecular docking analysis was conducted in order to determine the potential mechanism of action of the synthesized compounds. The results indicated that there were binding interactions seen with the active sites of dihydrofolate reductase and enoyl ACP reductase. Additionally, important structural details were identified that play a critical role in sustaining the dual inhibitory activity. These findings were useful for the development of future dual inhibitors. Therefore, this study provided strong evidence that several synthesized molecules could exert their antitubercular properties at the cellular level through multi-target inhibition. By shedding light on the mechanisms through which these compounds exert their inhibitory effects, this research opens up promising avenues for the future development of dual inhibitors with enhanced antibacterial and antitubercular properties. The study's findings underscore the importance of multi-target approaches in drug design, providing a strong foundation for the design and optimization of novel compounds that can effectively target bacterial infections at the cellular level.

Identifiants

pubmed: 38739587
doi: 10.1371/journal.pone.0303173
pii: PONE-D-23-41177
doi:

Substances chimiques

Antitubercular Agents 0
Tetrahydrofolate Dehydrogenase EC 1.5.1.3
Pyrroles 0
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) EC 1.3.1.9
Folic Acid Antagonists 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0303173

Informations de copyright

Copyright: © 2024 Mahnashi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Mater H Mahnashi (MH)

Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia.

Sravanthi Avunoori (S)

Department of Pharmaceutical Chemistry, Novel Drug Design and Discovery Laboratory, SET's College of Pharmacy, Sangolli Rayanna Nagar, Dharwad, Karnataka, India.

Sanjay Gopi (S)

Department of Pharmaceutical Chemistry, Novel Drug Design and Discovery Laboratory, SET's College of Pharmacy, Sangolli Rayanna Nagar, Dharwad, Karnataka, India.

Ibrahim Ahmed Shaikh (IA)

Department of Pharmacology, College of Pharmacy, Najran University, Najran, Saudi Arabia.

Ahmed Saif (A)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.

Farkad Bantun (F)

Faculty of Medicine, Department of Microbiology, Umm Al-Qura University, Makkah, Saudi Arabia.

Hani Saleh Faidah (HS)

Faculty of Medicine, Department of Microbiology, Umm Al-Qura University, Holy Makkah, Kingdom of Saudi Arabia.

Abdulrahman Ali Alhadi (AA)

Faculty of Medicine, Department of Microbiology, Umm Al-Qura University, Holy Makkah, Kingdom of Saudi Arabia.

Jaber Hassan Alshehri (JH)

Microbiology Section Pathology and Laboratory Medicine, Armed Forces Hospital Southern Region, Khamis Mushait, Kingdom of Saudi Arabia.

Abdullah Ali Alharbi (AA)

Microbiology Section Pathology and Laboratory Medicine, Armed Forces Hospital Southern Region, Khamis Mushait, Kingdom of Saudi Arabia.

Prem Kumar S R (PK)

Department of Pharmaceutical Chemistry, MVM College of Pharmacy, Yelahanka, Bengaluru, Karnataka, India.

Shrinivas D Joshi (SD)

Department of Pharmaceutical Chemistry, Novel Drug Design and Discovery Laboratory, SET's College of Pharmacy, Sangolli Rayanna Nagar, Dharwad, Karnataka, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH